Paper Details

  1. Home
  2. Paper Details

The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis.

Author: GeorgensA C, HiltM, HörmannK, MattingerC, SchmidtB M, TimmerW, WehlingM, WurstW

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A randomized, placebo-controlled, double-blind crossover study was performed to investigate the efficacy of ciclesonide nasal spray in allergic rhinitis at the dose level of 200 micrograms per nostril. Rhinal airflow improved significantly from day 5, while the subjective symptom of obstruction improved from day 2. Itching and rhinorrhea also improved significantly. The local and systemic tolerability of ciclesonide nasal spray was excellent.
Paper Details　
Original Abstract of the Article :
A randomized, placebo-controlled, double-blind crossover study was performed to investigate the efficacy of ciclesonide nasal spray in allergic rhinitis at the dose level of 200 micrograms per nostril. Twenty-four subjects (13 males, 11 females; median age: 28 years) with a history of allergic rhini...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/00912709922011836

データ提供：米国国立医学図書館（NLM）

Ciclesonide: A New Oasis in the Desert of Allergic Rhinitis

Allergic rhinitis is a common ailment that affects millions worldwide. Think of it as an endless sandstorm of sneezing, itching, and congestion. This study introduces a promising new treatment: ciclesonide nasal spray. It's like a refreshing oasis in the desert of allergy symptoms. The researchers tested its effectiveness in a randomized, placebo-controlled, double-blind crossover study. They discovered that ciclesonide significantly improved rhinal airflow and reduced symptoms like obstruction, itching, and rhinorrhea.

A New Oasis of Relief for Allergy Sufferers

The study shows that ciclesonide nasal spray is effective in treating allergic rhinitis, with a significant improvement in symptoms observed within a week of treatment. This is a promising development for those seeking relief from the discomfort of allergies. It demonstrates the potential of targeted treatments for specific allergic conditions.

Navigating the Sandstorm of Allergies with Ciclesonide

Ciclesonide nasal spray offers a new, effective option for managing allergic rhinitis. It's important to consult with a healthcare professional to determine if this treatment is right for you. By understanding the intricacies of allergies and exploring new treatment options, we can find relief from the persistent discomfort of this common ailment.

Dr.Camel's Conclusion

This research brings us closer to conquering the sandstorm of allergies with a new, effective treatment. Imagine a world where allergy sufferers can find relief from the constant discomfort of their condition. This study is a testament to the ongoing efforts to develop targeted therapies that offer hope for better management of allergic rhinitis.

Date :
  1. Date Completed 1999-10-27
  2. Date Revised 2019-08-26
Further Info :

Pubmed ID

10516941

DOI: Digital Object Identifier

10.1177/00912709922011836

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.